Market Research Logo

Ablation Devices Global Market - Forecast to 2023

Ablation Devices Global Market - Forecast to 2023

Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care. 

The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.

By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.
The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.

The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
North America
Europe
Asia-Pacific
Rest of the World (RoW)


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing Aging Population
3.3.1.2 Rising Incidence of Cancer and Cardiovascular Diseases
3.3.1.3 Growing Adoption of Minimally Invasive Procedures
3.3.1.4 Improving Reimbursement Scenario In Established Markets
3.3.1.5 Emergence of Next-Generation Ablation Products and Technologies
3.3.1.6 Increasing Number of Ablation Procedures
3.3.1.7 Increasing Funding for the Development of Novel Ablation Device
3.3.1.8 Emerging APAC Markets
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Reuse And Reprocessing of Devices in Developing Countries
3.3.2.2 Healthcare Cost Containment Measures
3.3.2.3 Stringent Regulatory Approvals
3.3.2.4 Challenges in Therapeutic Procedures
3.4 UPCOMING TECHNOLOGY
3.5 REIMBURSEMENT
3.6 REGULATORY AFFAIRS
3.6.1 U.S.
3.6.2 EUROPE
3.6.3 INDIA
3.6.4 CHINA
3.6.5 JAPAN
3.7 PATENT TRENDS
3.8 SUPPLY CHAIN ANALYSIS
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 RIVALRY AMONG EXISTING COMPETITORS
3.10 MARKET SHARE ANALYSIS
3.10.1 MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS
3.10.2 MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS
3.10.3 MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS
4 ABLATION DEVICES GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 THERMAL ABLATION
4.2.1 RADIOFREQUENCY ABLATION
4.2.2 LASER ABLATION TECHNOLOGY
4.2.3 MICROWAVE ABLATION TECHNOLOGY
4.2.4 ULTRASOUND ABLATION TECHNOLOGY
4.2.5 RADIATION ABLATION TECHNOLOGY
4.2.6 CRYOABLATION TECHNOLOGY
4.2.7 HYDROTHERMAL ABLATION TECHNOLOGY
4.3 NON-THERMAL TECHNOLOGY BASED ABLATION
4.3.1 ELECTROPORATION ABLATION TECHNOLOGY
4.3.2 MECHANICAL ABLATION TECHNOLOGY
4.3.3 OTHERS
5 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 ONCOLOGY
5.3 CARDIOVASCULAR
5.3.1 ATRIAL FIBRILATION (AF/AFIB)
5.3.2 VENTRICULAR TACHYCARDIA (VT)
5.3.3 OTHERS
5.4 OPHTHALMOLOGY
5.5 COSMETOLOGY
5.6 GYNECOLOGY
5.7 GENERAL SURGERY
5.8 UROLOGY
5.9 ORTHOPEDICS
5.10 PAIN MANAGEMENT
5.11 OTHER
6 ABLATION DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTRES
6.4 SPECIALITY CLINICS
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 U.K.
7.3.2 GERMANY
7.3.3 FRANCE
7.3.4 OTHERS
7.4 ASIA PACIFIC
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF THE WORLD
7.5.1 MIDDLE EAST
7.5.2 BRAZIL
7.5.3 OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS
8.2 MERGERS AND ACQUISITIONS
8.3 APPROVAL
8.4 NEW PRODUCT LAUNCH
8.5 AGREEMENTS PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.6 BUSINESS EXPANSION
9 MAJOR PLAYER PROFILES
9.1 ABBOTT LABORATORIES (ST JUDE MEDICAL)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ANGIODYNAMICS INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ARTICURE INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BOSTON SCIENTIFIC CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 CONMED CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 ELEKTA AB
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 HOLOGIC INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 OLYMPUS CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITH & NEPHEW PLC
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 STRYKER CORPORATION
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS
9.13 VARIAN MEDICAL SYSTEMS
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCT PORTFOLIO
9.13.4 KEY DEVELOPMENTS
9.13.5 BUSINESS STRATEGY
9.13.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report